Come and meet us

A common research on three pathologies

ManRos Therapeutics develops novel drug candidates acting against severe pathologies, namely cystic fibrosis, neurodegenerative disorders (Alzheimer’s disease and Down syndrome), and some renal diseases (including polycystic kidney disease). Anomalies in phosphorylation are observed in the three pathologies on which ManRos Therapeutics carries out its research: they share common targets and similar mechanisms.SciencePipeline

A leading researcher and a pharmaceutical industry expert

ManRos Therapeutics is led by a specialist in cellular and molecular biology, Dr. Laurent Meijer, and a pharmaceutical industry expert, Dr. Philippe de Lavenne.About